Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Fabric Networks purchases commercial license from Arqit to deploy quantum‑safe networks at scale
-
Classiq announced the appointment of Regev (Reggie) Yativ as its new Chief Revenue Officer (CRO) to run its global GTM operations.
-
Quantum allegedly misstated revenue in FY25, forcing a restatement of Q3 2024 results. Investors claim false statements caused damages.
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Quantum Corporation To Contact Him Directly To Discuss Their Options If you...
-
TORONTO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company...
-
GNE 2025, Nov 10-14 in Dallas, will showcase how NaaS for AI, secure networking, automation, and next-gen infrastructure are redefining digital services.
-
Boston, Aug. 11, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Quantum Computing: Technologies and Global Markets to 2030,” the market is projected to grow from $1.6...
-
Arqit selected to join Vodafone’s innovation centre Tomorrow Street: Scaleup X programme to explore new business opportunities
-
TORONTO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a...
-
TORONTO, July 31, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical company dedicated to building a portfolio of...